SuperworthEmergent BioSolutions shares outstanding EBS
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 51.6M
- On a year earlier
- −4.8%
- fewer shares
Emergent BioSolutions had 51.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 4.8% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 52.3M | −4% |
| FY2024 | 54.2M | +4% |
| FY2023 | 52.1M | +5% |
| FY2022 | 49.8M | −7% |
| FY2021 | 53.5M | −2% |
| FY2020 | 54.4M | +3% |
| FY2019 | 52.7M | +4% |
| FY2018 | 50.8M | −0% |
| FY2017 | 51M | +0% |
| FY2016 | 50.8M | +199% |
| FY2015 | 17M | −75% |
| FY2014 | 69.3M | +85% |
| FY2013 | 37.5M | +3% |
| FY2012 | 36.4M | −0% |
| FY2011 | 36.5M | +5% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 51.6M | −5% | |
| Q1 FY26 | 56.5M | −1% | |
| Q4 FY25 | 52.3M | −4% | |
| Q3 FY25 | 56.5M | +2% | |
| Q2 FY25 | 54.2M | +3% | |
| Q1 FY25 | 57.3M | +10% | |
| Q4 FY24 | 54.2M | +4% | |
| Q3 FY24 | 55.6M | +7% | |
| Q2 FY24 | 52.6M | +4% | |
| Q1 FY24 | 52.2M | +4% | |
| Q4 FY23 | 52.1M | +5% | |
| Q3 FY23 | 51.8M | +4% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Emergent BioSolutions
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.